Main Products/ Services/ Pipelines & Platforms
Mycenax is a 20-year bio-CDMO providing services for recombinant proteins, enzymes, mAb, BsAb, antibody-drug conjugates (ADC), and cell therapy products. • Druggability • Cell Line Development • Process Development • Analytical Method Development • Formulation Development • GMP Production • Aseptic Fill and Finish
Business Interests
Mycenax is a fully dedicated bio-CDMO. We also offer an open platform of novel technologies from our collaborators, such as ADCC enhancing technology (CHO pharma) and site-specific linkers for ADC, to enhance our customers’projects in terms of product quality and efficacy.
Contact Info
Lin-Lu Tseng, Ph.D.
Associate BD Manager
+886-3-6670880-5115
linlu.tseng@mycenax.com.tw